allantoin has been researched along with Hematologic Malignancies in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Allantoin was analyzed as the product of uric acid oxidation." | 1.31 | Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation. ( Berger, HM; Dürken, M; Finckh, B; Fischer, R; Herrnring, C; Kohlschütter, A; Kohlschütter, B; Moison, RM; Nagel, S; Nielsen, P; Pichlmeier, U; Zander, AR, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dürken, M | 1 |
Herrnring, C | 1 |
Finckh, B | 1 |
Nagel, S | 1 |
Nielsen, P | 1 |
Fischer, R | 1 |
Berger, HM | 1 |
Moison, RM | 1 |
Pichlmeier, U | 1 |
Kohlschütter, B | 1 |
Zander, AR | 1 |
Kohlschütter, A | 1 |
1 other study available for allantoin and Hematologic Malignancies
Article | Year |
---|---|
Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation.
Topics: Allantoin; Antineoplastic Agents; Antioxidants; Bone Marrow Transplantation; Busulfan; Combined Moda | 2000 |